Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) announced the initiation of patient dosing in a clinical program designed to evaluate the safety ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE